Table 3.
Mean and Standard Deviation of baseline HRQoL scale scores of the whole patient population and by disease site at baseline (N = 16,210).
| HRQoL Scale | Overall | Anal | Bladder | Brain | Breast | Colorectal | Endometrial | Gastric | Head and Neck | Lung |
|---|---|---|---|---|---|---|---|---|---|---|
| All observations | 16,210 | 60 | 228 | 822 | 3466 | 1693 | 92 | 324 | 330 | 2732 |
| Physical functioning | 80 (21) | 82 (20) | 70 (26) | 79 (23) | 90 (15) | 79 (19) | 75 (23) | 87 (16) | 87 (17) | 72 (21) |
| Role functioning | 71 (32) | 74 (29) | 57 (37) | 65 (33) | 85 (24) | 74 (28) | 64 (33) | 77 (28) | 82 (26) | 67 (31) |
| Emotional functioning | 73 (22) | 63 (24) | 65 (27) | 73 (23) | 70 (21) | 79 (19) | 68 (24) | 72 (23) | 73 (23) | 74 (23) |
| Cognitive functioning | 84 (21) | 78 (25) | 80 (25) | 70 (27) | 85 (19) | 87 (17) | 83 (21) | 85 (20) | 89 (17) | 84 (20) |
| Social functioning | 76 (28) | 78 (26) | 69 (33) | 68 (30) | 84 (23) | 74 (27) | 76 (28) | 77 (28) | 86 (21) | 73 (27) |
| Global health status/QoL | 65 (23) | 63 (23) | 50 (25) | 64 (23) | 74 (21) | 63 (22) | 64 (23) | 66 (23) | 62 (22) | 60 (22) |
| Fatigue | 33 (26) | 33 (26) | 46 (31) | 35 (25) | 23 (21) | 35 (24) | 35 (27) | 33 (27) | 26 (25) | 39 (25) |
| Nausea/vomiting | 15 (20) | 5 (14) | 12 (22) | 14 (18) | 10 (16) | 19 (18) | 10 (18) | 11 (19) | 4 (13) | 22 (20) |
| Pain | 26 (28) | 33 (32) | 41 (36) | 13 (21) | 18 (23) | 27 (27) | 30 (30) | 27 (27) | 28 (25) | 27 (28) |
| Dyspnoea | 18 (26) | 12 (24) | 19 (27) | 11 (21) | 9 (19) | 21 (25) | 14 (26) | 15 (24) | 13 (22) | 32 (30) |
| Insomnia | 30 (31) | 39 (33) | 39 (37) | 26 (32) | 31 (29) | 26 (28) | 35 (32) | 28 (30) | 27 (30) | 27 (30) |
| Appetite loss | 20 (29) | 18 (26) | 36 (38) | 10 (22) | 11 (21) | 25 (29) | 28 (30) | 19 (28) | 22 (30) | 25 (31) |
| Constipation | 15 (26) | 23 (33) | 35 (36) | 13 (25) | 9 (19) | 15 (25) | 24 (33) | 15 (25) | 15 (26) | 17 (27) |
| Diarrhoea | 8 (18) | 8 (15) | 8 (20) | 5 (15) | 6 (15) | 11 (21) | 9 (20) | 18 (28) | 4 (13) | 6 (16) |
| Financial problems | 17 (28) | 15 (24) | 13 (26) | 14 (27) | 15 (27) | 17 (27) | 14 (26) | 18 (29) | 18 (28) | 22 (31) |
| HRQoL scale | Lymphoma | Melanoma | Mixed population | Multiple myeloma | Ovarian | Pancreatic | Prostate | Soft tissue sarcoma | Testicular |
|---|---|---|---|---|---|---|---|---|---|
| All observations | 348 | 861 | 811 | 318 | 2269 | 516 | 645 | 425 | 270 |
| Physical functioning | 78 (21) | 92 (12) | 60 (27) | 78 (17) | 75 (22) | 75 (21) | 90 (14) | 77 (22) | 82 (23) |
| Role functioning | 57 (34) | 84 (24) | 50 (34) | 69 (29) | 59 (35) | 61 (33) | 91 (19) | 71 (31) | 57 (35) |
| Emotional functioning | 67 (24) | 82 (18) | 68 (23) | 82 (18) | 69 (24) | 67 (24) | 83 (17) | 74 (23) | 67 (24) |
| Cognitive functioning | 84 (21) | 93 (14) | 76 (24) | 86 (17) | 81 (22) | 81 (22) | 87 (16) | 85 (20) | 87 (19) |
| Social functioning | 72 (30) | 88 (20) | 64 (31) | 70 (27) | 67 (31) | 66 (30) | 93 (15) | 75 (28) | 68 (31) |
| Global health status/QoL | 55 (22) | 78 (18) | 53 (24) | 67 (19) | 59 (23) | 54 (23) | 77 (18) | 64 (23) | 58 (23) |
| Fatigue | 49 (26) | 15 (18) | 47 (28) | 33 (21) | 41 (26) | 45 (27) | 15 (18) | 33 (25) | 40 (28) |
| Nausea/vomiting | 10 (18) | 1 (6) | 34 (23) | 22 (18) | 17 (23) | 21 (21) | 2 (7) | 7 (15) | 12 (19) |
| Pain | 34 (32) | 12 (20) | 56 (32) | 30 (26) | 30 (28) | 38 (30) | 10 (18) | 29 (30) | 44 (34) |
| Dyspnoea | 30 (30) | 5 (14) | 25 (30) | 14 (21) | 19 (27) | 17 (25) | 12 (21) | 20 (27) | 17 (27) |
| Insomnia | 49 (36) | 18 (26) | 39 (33) | 25 (28) | 35 (32) | 34 (31) | 16 (23) | 26 (29) | 38 (35) |
| Appetite loss | 29 (33) | 3 (12) | 27 (33) | 14 (24) | 25 (33) | 42 (35) | 3 (11) | 17 (27) | 33 (33) |
| Constipation | 16 (27) | 5 (13) | 24 (32) | 7 (18) | 23 (31) | 27 (33) | 7 (18) | 15 (26) | 17 (28) |
| Diarrhoea | 9 (20) | 6 (15) | 8 (20) | 7 (16) | 10 (21) | 15 (26) | 6 (15) | 7 (17) | 8 (18) |
| Financial problems | 23 (33) | 14 (26) | 20 (30) | 23 (30) | 14 (26) | 21 (30) | 3 (11) | 19 (29) | 23 (32) |